TREA

97442064 - YOCHANRA

Follow

Information

  • Trademark
  • 97442064
  • Serial Number
    97442064
  • Registration Number
    7395011
  • Filing Date
    June 03, 2022
    2 years ago
  • Registration Date
    May 28, 2024
    8 months ago
  • Transaction Date
    May 28, 2024
    8 months ago
  • Status Date
    May 28, 2024
    8 months ago
  • Published for Opposition Date
    March 12, 2024
    10 months ago
  • Location Date
    May 27, 2024
    8 months ago
  • Status Code
    700
  • Current Location
    FILE REPOSITORY (FRANCONIA)
    Employee Name
    MAYES, LAURIE ANN
  • Attorney Docket Number
    0579-0953US1
    Attorney Name
    Michael T. Smith
  • Owners
Information
Mark Drawing Code
3
Mark Identification
YOCHANRA
Case File Statements
  • DM0000: The mark consists of a spherical design formed by three stacked offset curved lines on the bottom and three stacked offset curved dotted lines on the top with the word "YOCHANRA" to the right of the design.
  • GS0051: Medicines for human purposes for treatment of cancer, cardiovascular diseases and disorders, metabolic diseases and disorders, anemia and associated anemia diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, nervous system diseases and disorders, infection and inflammation, skeletal or chondrocyte disorders, immune and autoimmune diseases, hematological disorders; pharmaceutical preparations for treatment of cancer, cardiovascular diseases and disorders, metabolic diseases and disorders, anemia and associated anemia diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, nervous system diseases and disorders, infection and inflammation, skeletal or chondrocyte disorders, immune and autoimmune diseases, hematological disorders; drugs for medical purposes for treatment of cancer, cardiovascular diseases and disorders, metabolic diseases and disorders, anemia and associated anemia diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, nervous system diseases and disorders, infection and inflammation, skeletal or chondrocyte disorders, immune and autoimmune diseases, hematological disorders; chemico-pharmaceutical preparations for treatment of cancer, cardiovascular diseases and disorders, metabolic diseases and disorders, anemia and associated anemia diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, nervous system diseases and disorders, infection and inflammation, skeletal or chondrocyte disorders, immune and autoimmune diseases, hematological disorders; chemical preparations for medical purposes for treatment of cancer, cardiovascular diseases and disorders, metabolic diseases and disorders, anemia and associated anemia diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, nervous system diseases and disorders, infection and inflammation, skeletal or chondrocyte disorders, immune and autoimmune diseases, hematological disorders; biological preparations for medical purposes for treatment of cancer, cardiovascular diseases and disorders, metabolic diseases and disorders, anemia and associated anemia diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, nervous system diseases and disorders, infection and inflammation, skeletal or chondrocyte disorders, immune and autoimmune diseases, hematological disorders; bulk medicines for treatment of cancer, cardiovascular diseases and disorders, metabolic diseases and disorders, anemia and associated anemia diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, nervous system diseases and disorders, infection and inflammation, skeletal or chondrocyte disorders, immune and autoimmune diseases, hematological disorders; biochemical medicines for treatment of cancer, cardiovascular diseases and disorders, metabolic diseases and disorders, anemia and associated anemia diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, nervous system diseases and disorders, infection and inflammation, skeletal or chondrocyte disorders, immune and autoimmune diseases, hematological disorders; chemical preparations for pharmaceutical purposes for treatment of cancer, cardiovascular diseases and disorders, metabolic diseases and disorders, anemia and associated anemia diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, nervous system diseases and disorders, infection and inflammation, skeletal or chondrocyte disorders, immune and autoimmune diseases, hematological disorders; medicines in the nature of tablets for treatment of cancer, cardiovascular diseases and disorders, metabolic diseases and disorders, anemia and associated anemia diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, nervous system diseases and disorders, infection and inflammation, skeletal or chondrocyte disorders, immune and autoimmune diseases, hematological disorders; medicines for human purposes for treatment of cancer, cardiovascular diseases and disorders, metabolic diseases and disorders, anemia and associated anemia diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, nervous system diseases and disorders, infection and inflammation, skeletal or chondrocyte disorders, immune and autoimmune diseases, hematological disorders in the nature of capsule; injectable medicines for treatment of cancer, cardiovascular diseases and disorders, metabolic diseases and disorders, anemia and associated anemia diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, nervous system diseases and disorders, infection and inflammation, skeletal or chondrocyte disorders, immune and autoimmune diseases, hematological disorders
  • CC0000: Color is not claimed as a feature of the mark.
Case File Event Statements
  • 6/7/2022 - 2 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 6/13/2022 - 2 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 6/14/2022 - 2 years ago
    3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC
  • 2/25/2023 - a year ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 3/3/2023 - a year ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 3/3/2023 - a year ago
    6 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 3/3/2023 - a year ago
    7 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 4/14/2023 - a year ago
    8 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 8/28/2023 - a year ago
    9 - ASSIGNED TO LIE Type: ALIE
  • 8/28/2023 - a year ago
    10 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 8/28/2023 - a year ago
    11 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 9/12/2023 - a year ago
    12 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 9/12/2023 - a year ago
    13 - TEAS WITHDRAWAL OF ATTORNEY RECEIVED Type: WOAR
  • 9/12/2023 - a year ago
    14 - WITHDRAWAL OF ATTORNEY GRANTED Type: WOAG
  • 9/27/2023 - a year ago
    15 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 10/17/2023 - a year ago
    16 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 10/17/2023 - a year ago
    17 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 11/9/2023 - a year ago
    18 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR
  • 11/9/2023 - a year ago
    19 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 11/9/2023 - a year ago
    20 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 11/9/2023 - a year ago
    21 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 11/9/2023 - a year ago
    22 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 12/12/2023 - a year ago
    23 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 1/10/2024 - a year ago
    24 - TEAS PETITION TO AMEND BASIS RECEIVED Type: TPAD
  • 2/6/2024 - 12 months ago
    25 - ASSIGNED TO PETITION STAFF Type: APET
  • 2/7/2024 - 11 months ago
    26 - PETITION TO DIRECTOR - CHANGE BASIS - GRANTED Type: PCBG
  • 2/7/2024 - 11 months ago
    27 - JURISDICTION RESTORED TO EXAMINING ATTORNEY Type: JURT
  • 2/8/2024 - 11 months ago
    28 - NOTICE OF ALLOWANCE CANCELLED Type: IUCN
  • 2/21/2024 - 11 months ago
    30 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 2/21/2024 - 11 months ago
    29 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 3/12/2024 - 10 months ago
    31 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 3/12/2024 - 10 months ago
    32 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 5/28/2024 - 8 months ago
    33 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 5/28/2024 - 8 months ago
    34 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC